|
TOMM70A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.441900E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.362900E-04 |
| Normal-vs-Stage2 |
3.375800E-01 |
| Normal-vs-Stage3 |
5.499600E-02 |
| Normal-vs-Stage4 |
7.995900E-02 |
| Stage1-vs-Stage2 |
2.744400E-01 |
| Stage1-vs-Stage3 |
6.719600E-01 |
| Stage1-vs-Stage4 |
9.521400E-01 |
| Stage2-vs-Stage3 |
5.457400E-01 |
| Stage2-vs-Stage4 |
4.580600E-01 |
| Stage3-vs-Stage4 |
8.105000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.553090E-04 |
| Normal-vs-AfricanAmerican |
6.573000E-01 |
| Normal-vs-Asian |
1.147950E-01 |
| Caucasian-vs-AfricanAmerican |
4.176400E-01 |
| Caucasian-vs-Asian |
2.072800E-01 |
| AfricanAmerican-vs-Asian |
2.574400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.170230E-01 |
| Normal-vs-Female |
9.0121999996029E-07 |
| Male-vs-Female |
2.049200E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.053000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.43239999999845E-05 |
| Normal-vs-Age(61-80Yrs) |
1.802150E-02 |
| Normal-vs-Age(81-100Yrs) |
1.446610E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.755000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.803200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.188400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.064000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.961200E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.223700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.197800E-02 |
| Normal-vs-Grade 2 |
1.032610E-04 |
| Normal-vs-Grade 3 |
5.161300E-03 |
| Normal-vs-Grade 4 |
9.790000E-01 |
| Grade 1-vs-Grade 2 |
7.394000E-01 |
| Grade 1-vs-Grade 3 |
8.571400E-01 |
| Grade 1-vs-Grade 4 |
1.131390E-01 |
| Grade 2-vs-Grade 3 |
4.422400E-01 |
| Grade 2-vs-Grade 4 |
1.564100E-02 |
| Grade 3-vs-Grade 4 |
7.399800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.12549996994704E-09 |
| Normal-vs-ccB subtype |
2.415600E-01 |
| ccA subtype-vs-ccB subtype |
5.370300E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.425800E-04 |
| Normal-vs-N1 |
9.436400E-02 |
| N0-vs-N1 |
5.020800E-01 |
|
|
